Kolmar BNH Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 02:12 pm IST
Share
Kolmar BNH Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 963.9 million compared to KRW 376.53 million a year ago. Net income was KRW 9,728.29 million compared to KRW 13,177.53 million a year ago. Basic earnings per share from continuing operations was KRW 329 compared to KRW 446 a year ago. Basic earnings per share was KRW 329 compared to KRW 446 a year ago.
For the nine months, sales was KRW 2,211.15 million compared to KRW 4,274.69 million a year ago. Net income was KRW 37,194.07 million compared to KRW 51,776.37 million a year ago. Basic earnings per share from continuing operations was KRW 1,259 compared to KRW 1,753 a year ago. Basic earnings per share was KRW 1,259 compared to KRW 1,753 a year ago.
KolmarBNH Co., Ltd, formerly MIRAE ASSET NO.2 SPECIAL PURPOSE ACQUISITION COMPANY, is a Korea-based company principally engaged in manufacture and distribution of health functional foods, cosmetics and pharmaceuticals. The Company mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The Company also produces cosmetics using natural extracts, and other pharmaceuticals. The Company also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
KOLMAR BNH CO.,LTD. 
